Monaco Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.9M Sell
3,167,979
-862,177
-21% -$5.74M 2.13% 5
2026
Q1
$22M Buy
4,030,156
+2,073,209
+106% +$11.6M 4.05% 8
2025
Q4
$13.7M Buy
1,956,947
+1,201,947
+159% +$9.41M 2.37% 11
2025
Q3
$5.84M Buy
755,000
+180,000
+31% +$1.4M 0.35% 29
2025
Q2
$5.01M Buy
575,000
+75,000
+15% +$544K 0.88% 24
2025
Q1
$3.98M Buy
500,000
+90,000
+22% +$910K 0.81% 19
2024
Q4
$3.73M Sell
410,000
-460,791
-53% -$4.45M 0.54% 30
2024
Q3
$7.99M Buy
870,791
+745,791
+597% +$6.17M 1.16% 16
2024
Q2
$1.22M Buy
+125,000
New +$1.52M 0.19% 40

Other funds holding TDOC

Monaco Asset Management's TDOC Position: Q2 2026 in Review

Monaco Asset Management reduced its Teladoc Health (TDOC) stake by 21% in Q2 2026, selling an estimated $5.74M and leaving 3,167,979 shares worth $26.9M. The position accounts for 2.13% of the portfolio, ranked #5.

Monaco Asset Management first reported a position in TDOC in Q2 2024 and has held it in 9 quarters since. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Monaco Asset Management held 3,167,979 shares of Teladoc Health worth $26.9M as of Q2 2026.
  • Monaco Asset Management sold 862,177 Teladoc Health shares in Q2 2026, an estimated $5.74M.
  • Teladoc Health made up 2.13% of Monaco Asset Management's portfolio in Q2 2026, its #5 holding.
  • Monaco Asset Management first reported a position in Teladoc Health in Q2 2024 and has held it in 9 quarters since.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Monaco Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.